SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Dado Ruvic—Reuters

169

Roche Group

RHHBY

Switzerland

Looking for leads, investment insights, or competitive intelligence?

CEO

Severin Schwan

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Basel, Switzerland

Years on Global 500 List

23

Employees

94,052

Figures prepared in accordance with International Accounting Standards.
Roche Group is also featured in these fortune lists
Key Financials (Last Fiscal Year)
($ Millions)% change
Revenues ($M)$53,4272.0%
Profits ($M)$9,719.95.5%
Assets ($M)$75,609
Total Stockholder Equity ($M)$23,534
Profit Ratios
Profit as % of Revenues18.2%
Profits as % of Assets12.9%
Profits as % of Stockholder Equity41.3%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Roche Group

This New Drug Combination Doubles the Chance of Keeping Lung Cancer at Bay

The finding could result in annual sales of $4.6 billion by 2023.

Read More →
Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?

The FDA approved the first cancer medicine "biosimilar" Thursday.

Read More →
Why Merck's Keytruda Just Became a Lung Cancer Game Changer

A new FDA approval gives Merck a huge advantage over its rivals.

Read More →
The FDA Has Approved a Crazy Number of New and Groundbreaking Drugs This Year

20 new drugs in 2017 to date. There were just 22 in all of 2016.

Read More →